FOLH1 and urothelial carcinoma: The positive PSMA expression patterns noted among evaluated canine uroepithelial carcinoma samples suggested that PSMA could not be used as a discriminatory marker to distinguish iUC and PCA, however, PSMA-targeting strategies could be considered more broadly applicable to uroepithelial carcinomas regardless of cellular origin in dogs.